Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Full access
Professional News
Published Online: 30 June 2017

NIH Partners With Industry to Stem Opioid Crisis

Nick ZagorskiAuthors Info & Affiliations
Publication: Psychiatrics News
Volume 52, Number 13
https://doi.org/10.1176/appi.pn.2017.7a10
Track CitationsAdd to favorites
Data from the Centers for Disease Control and Prevention suggest that more than 90 Americans die every day from opioid overdoses, an epidemic that seems to be becoming only more entrenched. To get in front of this public health crisis, the National Institutes of Health (NIH) is teaming up with the pharmaceutical industry in a three-pronged research initiative.
“Recent NIH-industry partnerships, such as the Accelerating Medicines Partnership, demonstrate the power of public–private collaboration in speeding the development of new medications,” wrote NIH Director Francis Collins, M.D., Ph.D., and National Institute on Drug Abuse Director Nora Volkow, M.D., in a special report published May 31 in the New England Journal of Medicine. “Ending the opioid crisis will require this kind of collaboration.”
This new public-private partnership will include short-, intermediate-, and long-term research strategies aimed at developing better opioid overdose-reversal interventions, finding new medications and technologies to treat opioid addiction, and developing nonaddictive therapies for chronic pain. In addition, a goal that cuts across all three focus areas is to reduce the time typically required to develop new safe and effective therapeutics by half.
In the article, Collins and Volkow highlighted existing drugs developed through such partnerships, including Probuphine, a long-lasting buprenorphine implant recently approved by the FDA, and Narcan nasal spray.
But while pharmacology will be front and center, Collins and Volkow stated that other clinical avenues will be pursued as well. These include brain-stimulation technologies such as repetitive transcranial magnetic stimulation, gene therapies that deliver anti-inflammatory proteins directly to sites of pain, and even opioid-targeted vaccines to keep these drugs out of the brain.
“The Role of Science in Addressing the Opioid Crisis” can be accessed here.

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatrics News
Volume 52 • Number 13 • June 17, 2017 – July 7, 2017
Pages: 1

History

Published online: 30 June 2017
Published in print: June 17, 2017 – July 7, 2017

Keyword

  1. opioid overdoses

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.